261 related articles for article (PubMed ID: 29293020)
1. Validation of a Cytotechnologist Manual Counting Service for the Ki67 Index in Neuroendocrine Tumors of the Pancreas and Gastrointestinal Tract.
Cottenden J; Filter ER; Cottreau J; Moore D; Bullock M; Huang WY; Arnason T
Arch Pathol Lab Med; 2018 Mar; 142(3):402-407. PubMed ID: 29293020
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different anti-Ki67 antibody clones and hot-spot sizes for assessing proliferative index and grading in pancreatic neuroendocrine tumours using manual and image analysis.
Owens R; Gilmore E; Bingham V; Cardwell C; McBride H; McQuaid S; Humphries M; Kelly P
Histopathology; 2020 Oct; 77(4):646-658. PubMed ID: 32617996
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of visual assessments of proliferation indices in gastroenteropancreatic neuroendocrine tumours.
Young HT; Carr NJ; Green B; Tilley C; Bhargava V; Pearce N
J Clin Pathol; 2013 Aug; 66(8):700-4. PubMed ID: 23703851
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.
Ozturk Sari S; Taskin OC; Gundogdu G; Yegen G; Onder S; Keskin M; Saglam S; Ozluk Y; Gulluoglu M; Mete O
Endocr Pathol; 2016 Jun; 27(2):162-70. PubMed ID: 26936845
[TBL] [Abstract][Full Text] [Related]
5. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors.
Kroneman TN; Voss JS; Lohse CM; Wu TT; Smyrk TC; Zhang L
Endocr Pathol; 2015 Sep; 26(3):255-62. PubMed ID: 26072124
[TBL] [Abstract][Full Text] [Related]
7. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.
Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z
Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284
[TBL] [Abstract][Full Text] [Related]
8. Synaptophysin-Ki67 double stain: a novel technique that improves interobserver agreement in the grading of well-differentiated gastrointestinal neuroendocrine tumors.
Matsukuma K; Olson KA; Gui D; Gandour-Edwards R; Li Y; Beckett L
Mod Pathol; 2017 Apr; 30(4):620-629. PubMed ID: 28084345
[TBL] [Abstract][Full Text] [Related]
9. [Tissue heterogeneity contributes to suboptimal precision of WHO 2010 scoring criteria for Ki67 labeling index in a subset of neuroendocrine neoplasms of the pancreas].
Liszka Ł
Pol J Pathol; 2016; 67(4):318-331. PubMed ID: 28547959
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 proliferation index in neuroendocrine tumors: Can augmented reality microscopy with image analysis improve scoring?
Satturwar SP; Pantanowitz JL; Manko CD; Seigh L; Monaco SE; Pantanowitz L
Cancer Cytopathol; 2020 Aug; 128(8):535-544. PubMed ID: 32401429
[TBL] [Abstract][Full Text] [Related]
11. Ki67 index and mitotic count: Correlation and variables affecting the accuracy of the quantification in endocrine/neuroendocrine tumors.
Huang W; Nebiolo C; Esbona K; Hu R; Lloyd R
Ann Diagn Pathol; 2020 Oct; 48():151586. PubMed ID: 32836178
[TBL] [Abstract][Full Text] [Related]
12. Grade Assignment by Ki-67 Proliferative Index, Mitotic Count, and Phosphohistone H3 Count in Surgically Resected Gastrointestinal and Pancreatic Neuroendocrine Tumors.
Murphy CE; McCormick KA; Shankaran V; Reddi DM; Swanson PE; Upton MP; Papanicolau-Sengos A; Khor S; Westerhoff M
Pancreas; 2017; 46(10):1359-1365. PubMed ID: 29040195
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an Image-based Automated Detection System in Detecting Ki67 Proliferation Index and Correlation with the Traditional Eye-Ball Method in Gastroenteropancreatic Neuroendocrine Tumors.
Dere Y; Ozkaraca O; Cetin G; Dere O
J Coll Physicians Surg Pak; 2019 Feb; 29(2):137-140. PubMed ID: 30700352
[TBL] [Abstract][Full Text] [Related]
14. Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies.
Reid MD; Bagci P; Ohike N; Saka B; Erbarut Seven I; Dursun N; Balci S; Gucer H; Jang KT; Tajiri T; Basturk O; Kong SY; Goodman M; Akkas G; Adsay V
Mod Pathol; 2015 May; 28(5):686-94. PubMed ID: 25412850
[TBL] [Abstract][Full Text] [Related]
15. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
[TBL] [Abstract][Full Text] [Related]
16. Potential Pitfalls in Diagnostic Digital Image Analysis: Experience with Ki-67 and PHH3 in Gastrointestinal Neuroendocrine Tumors.
Hacking SM; Sajjan S; Lee L; Ziemba Y; Angert M; Yang Y; Jin C; Chavarria H; Kataria N; Jain S; Nasim M
Pathol Res Pract; 2020 Mar; 216(3):152753. PubMed ID: 31761497
[TBL] [Abstract][Full Text] [Related]
17. Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index.
Lea D; Gudlaugsson EG; Skaland I; Lillesand M; Søreide K; Søreide JA
Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):499-505. PubMed ID: 33758143
[TBL] [Abstract][Full Text] [Related]
18. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
McCall CM; Shi C; Cornish TC; Klimstra DS; Tang LH; Basturk O; Mun LJ; Ellison TA; Wolfgang CL; Choti MA; Schulick RD; Edil BH; Hruban RH
Am J Surg Pathol; 2013 Nov; 37(11):1671-7. PubMed ID: 24121170
[TBL] [Abstract][Full Text] [Related]
19. Ki67 Scoring in Pancreatic Neuroendocrine Tumors By a New Method.
Öztürk Sari Ş; Taşkin OÇ; Yegen G; Özlük Y; Güllüoğlu M
Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):283-287. PubMed ID: 27389557
[TBL] [Abstract][Full Text] [Related]
20. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
